John Szilagyi (left) is a Principal Scientist at Bristol Myers Squibb (NJ, USA), working in nonclinical development and investigative toxicology, with a focus on the development of models to study ...

Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...

Biomedical research is shifting from traditional 2D monolayer cell cultures to advanced 3D cell culture technologies, which more accurately replicate biological systems. This article explores the ...